Chapel Hill - Thomas Shea, MD, will serve a two-year term as chair of the Scientific Advisory Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR). He was previously elected as chair-elect. The Advisory Committee establishes policy for, and provides scientific direction to the CIBMTR.
UNC completes miRNA and array analysis
Recent UNC-Chapel Hill graduate and former UNC Women’s Basketball player Jessica Breland – who now plays in the WNBA for the New York Liberty – was honored with the the 23rd annual Honda Inspiration Award.
Chapel Hill - The human immune system is a double-edged sword. While it is finely adapted to fighting potentially deadly viruses, such as the H1N1 influenza, the mechanisms it uses to fight pathogens can have negative effects such as inflammatory disorders or autoimmune diseases.
New drugs should work for rare blood disorder
Chapel Hill - UNC Lineberger Comprehensive Cancer Center honored three clinical oncology fellows with $5,000 awards for their research accomplishments and clinical excellence. These first-ever awards were given to Daniel Higginson, MD, Autumn McRee, MD, and Emma Rossi, MD.
Gary Rosson was honored by the NC Triangle Komen Race for the Cure as the 2011 winner of the Co-Survivor Award. Rosson is a research associate in the lab of UNC Lineberger faculty member Scott Bultman.
Dr. Shelley Earp, UNC Lineberger Comprehensive Cancer Center director, joined Nick Valvano, CEO of The V Foundation for Cancer Research, on ABC 11’s Heart of Carolina Perspectives show which aired on Sunday, June 19, 2011.
Finding points new direction for study of chronic Hepatitis C
Input sought from Fayetteville’s African-American and Latino communities
Each year, the President’s Cancer Panel assembles a group of experts to provide official testimony about the nation’s cancer agenda. The theme changes annually – for 2009-2010 the panel focused on “America’s Demographic and Cultural Transformation: Implications for Cancer.” A full report was released this spring.
2011 Statesman Award honors extraordinary voluntary efforts
UNC Lineberger’s Fellowship Program in Hematology/Oncology is being recognized by the American Society of Clinical Oncology (ASCO) this weekend at the organization’s annual meeting in Chicago, Illinois.
CHAPEL HILL, N.C. - The article "Why do men die earlier?" written by Bridget Murray-Law and published in the June 2011 issue of Monitor on Psychology, looks at new research that analyzes how men take care of themselves.
Dr. Stuart Gold is division chief of UNC Lineberger's pediatric hematology and oncology program.
LIVESTRONG® Survivorship Center of Excellence Network to Host Landmark Meeting on Survivorship Care and Advocacy in Response to 2011 Report Findings
Conference will be held in Washington, D.C., Sept. 15-16. UNC Lineberger Comprehensive Cancer Center is part of a collaborative effort among leading medical institutions brought together by LIVESTRONG.
Data will help scientists worldwide design better experiments.
University Cancer Research Fund updates, record poster session highlights of 2011 scientific retreat
The sixth annual UNC Lineberger scientific retreat drew a record number of posters – 68 – for the poster session and competition – and close to 150 people for the talks and reception.
Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.
Tom May used to donate blood, but not often. If he had it to do over, he’d give as much as possible. But he can’t.
CHAPEL HILL, N.C. – Carol Otey, PhD talks about the hope & health that has resulted from recent pancreatic research & collaboration on the May 14, 2011 broadcast of Here's to Your Health.
Chapel Hill - When cancer patients experience medical problems, they may visit emergency departments, but how often and for what reasons, there is little data.
A University of North Carolina at Chapel Hill study has joined the ranks of an elite group of programs recognized for their contributions to reducing cancer.
Innovative collaboration between physics and cell biology demonstrates pathway